Concepedia

Publication | Closed Access

Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial

DOI

40

Citations

15

References

2015

Year

Yu Bai, Ren Xu, Xiaofeng Zhang, Nonghua Lv, Xuegang Guo, Xinjian Wan, Nie Zhan-guo, Shu-Tang Han, Ping Bie, Dean Tian,
Endoscopy

Abstract

This study showed that somatostatin was effective and safe for the prevention of PEP and hyperamylasemia in ERCP patients.(ClinicalTrials.gov number, NCT01431781).

References

YearCitations

Page 1